Influence of complex solubility on formulations based on lambda carrageenan and basic drugs

AAPS PharmSciTech

Volumn 3, Issue 3, 2002, Pages

  Aguzzi, Carola ^a   Bonferoni, Maria Cristina ^a   Osorio Fortich, Maria Rosario ^b   Rossi, Silvia ^a   Ferrari, Franca ^a   Caramella, Carla ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Controlled release; Drug carrageenan complex; Hydration; Oral drug delivery; Solubility

Indexed keywords

AMFEBUTAMONE; BUFFER; CARRAGEENAN; CELLULOSE ACETATE; DILTIAZEM; DRUG CARRIER; HYDROXYPROPYLMETHYLCELLULOSE; METOPROLOL; METOPROLOL TARTRATE; PHOSPHATE; TRAMADOL; WATER;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ENTERIC COATED TABLET; GELATION; HYDRATION; METABOLISM; METHODOLOGY; PH; SOLUBILITY; STOMACH JUICE; TIME; TRANSPORT KINETICS; TURBIDIMETRY; WATER TRANSPORT;

BUFFERS; BUPROPION; CARRAGEENAN; CHEMISTRY; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DRUG CARRIERS; DRUG COMPOUNDING; GASTRIC JUICE; HYDROGEN-ION CONCENTRATION; METABOLISM; METHODS; METOPROLOL; PHOSPHATES; SOLUBILITY; TABLETS, ENTERIC-COATED; TIME FACTORS; TRAMADOL; WATER;

EID: 23144450230     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1007/BF02830625     Document Type: Article

References (15)

1. Kalinkova GN. Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations. Int J Pharm. 1999;187:1-15.
2. Nujoma YN, Kim C.J. A designer's polymer as an oral drug carrier (tablet) with pseudo-zero-order release kinetics. J Pharm Sci. 1996;85:1091-1095.
3. Konar N, Kim C.J. Drug release from drug-polyanion complex tablets: poly(acrylomido-2-methyl-1-propanesulfonate sodium-comethyl methacrylate). J Control Release. 1999;57:141-150.
4. FMC Corporation, Pharmaceutical Division, Philadelphia, PA, USA. Marine colloids carrageenan. Technical bulletin, 1993.
5. Bonferoni MC, Rossi S, Tamayo M, Pedraz JL, Dominguez Gil A, Caramella C. On the employment of lambda carrageenan in a matrix system, I: sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum. J Control Release. 1993;26:119-127.
6. Bonferoni MC, Rossi S, Ferrari F, Bertoni M, Bolhuis GK, Caramella C. On the employment of lambda carrageenan in a matrix system, III: optimization of a lambda carrageenan-HPMC hydrophilic matrix. J Control Release. 1998;51:231-239.
7. Bonferoni MC, Rossi S, Ferrari F, Bettinetti GP, Caramella C. Characterization of a diltiazem-lambda carrageenan complex. Int J Pharm. 2000;200:207-216.
8. Bonferoni MC, Rossi S, Ferrari F, Caramella C. Development of a once-a-day tablet formulation based on a diltiazem/carrageenan interaction product. In: Proceedings of the 2nd World Meeting APGI/APV, Paris, 25/28 May (1998). Pag 153-154.
9. Caramella C, Bonferoni MC. Patent application PCT/EP/98/06864.
10. Bonferoni MC, Rossi S, Ferrari F, Sorrenti M, Caramella C. Characterization of interaction products between carrageenan and some basic drugs. In: Proceedings of the 2nd World Meeting APGI/APV, Paris, 25/28 May (1998). Pag 71-72.
11. Klotz IM, Walker FM, Pivan RB. The binding of organic ions by proteins. J Am Chem Soc. 1946;68:1486-1490.
12. Ferrari F, Rossi S, Bertoni M, Caramella C, Geddo M.. Modelling of water penetration into fast disintegrating tablets. STP Pharma Sci. 1(2), (1991), 137-144.
13. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110-111.
14. Bonferoni MC, Rossi S, Ferrari F, Stavik E, Pena Romero A, Caramella C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS Pharm Sci Tech. 2000;1. Available at
15. Bonferoni MC, Rossi S, Tamayo M, Pedraz JL, Dominguez Gil A, Caramella C. On the employment of lambda carrageenan in a matrix system, II: lambda carrageenan and hydroxypropylmethylcellulose mixtures. J Control Release. 1994;30:175-182.